May 2015

Commonly used measures of performance for assessing patient access do not reflect PCMH-encouraged strategies to improve access that may be preferentially used by part-time physicians.

Variation in private spending reflects the ability of the local population to pay for healthcare, whereas variation in Medicare is more driven by health status.

Medicaid-insured type 2 diabetes mellitus patients, just like the uninsured, are more likely to be hospitalized through emergency/urgent admissions.

Glycemic control can lower the risk of diabetes-related complications, and delayed treatment intensification can impede optimal diabetes care.This study examines trends in hyperglycemia treatment intensification between 2002 and 2010.

A systematic review of insurance benefit designs with differential cost sharing for substitute prescription drugs.

We assessed challenges and barriers to annual diabetic eye examinations for a managed care Medicaid population and make recommendations to improve population-level screening.

This paper illustrates how Medicare Advantage plans and accountable care organizations could benefit from adopting innovative care delivery models, and suggests policy changes to accelerate spread.

A qualitative study of patient and provider perspectives regarding the after-visit summary and the patient portal features of the electronic health record.

A discussion on meaningful measurement and driving greater value in healthcare, and the role of the National Quality Forum.

This study shows that health plans use chronic care management programs as standard components of the overall approach to manage the health of their members.

Use of specialist visits decreased by patients whose primary care physicians transformed their practices into patient-centered medical homes, 1 year after medical home implementation.

The authors compared targeting strategies and characteristics of chronic disease care management programs delivered by primary care practices with one administered by a large health plan.

The authors examine 4 alternative payment models for oncology care that shift away from fee-for-service and move progressively toward greater bundling, either across providers or across payments.

Increased care fragmentation among chronically ill, commercially insured patients is associated with higher costs and lower quality of care.